Systems biology of JAK-STAT signalling in human malignancies

被引：60

作者：

Vera, Julio ^{[1
]}

Rateitschak, Katja ^{[1
]}

Lange, Falko ^{[1
,2
]}

Kossow, Christina ^{[1
]}

Wolkenhauer, Olaf ^{[1
]}

Jaster, Robert ^{[2
]}

机构：

[1] Univ Rostock, Dept Syst Biol & Bioinformat, D-18051 Rostock, Germany

[2] Univ Rostock, Fac Med, Div Gastroenterol, Dept Med 2, D-18057 Rostock, Germany

来源：

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY | 2011年 / 106卷 / 02期

关键词：

JAK-STAT; Cell signalling; Interferon-gamma; Pancreatic stellate cell; STAT1; Mathematical modelling; CHRONIC MYELOGENOUS LEUKEMIA; ERYTHROPOIETIN RECEPTOR; MATHEMATICAL-MODEL; PANCREATIC-CANCER; LYMPHOMA; MUTATION; GENE; HEMATOPOIESIS; TRANSDUCTION; ACTIVATION;

D O I：

10.1016/j.pbiomolbio.2011.06.013

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Originally implicated in the regulation of survival, proliferation and differentiation of haematopoietic cells, the JAK-STAT pathway has also been linked to developmental processes, growth control and maintenance of homeostasis in a variety of other cells and tissues. Although it remains a complex system, its relative simplicity and the availability of molecular data makes it particularly attractive for modelling approaches. In this review, we will focus on JAK-STAT signalling in the context of cancer and present efforts to investigate signalling dynamics with the help of mathematical models. We describe the modelling workflow that realises a systems biology approach and give an example for interferon-gamma signalling in pancreatic stellate cells. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：426 / 434

页数：9

共 50 条

[31] SnapShot: JAK-STAT signaling
Mertens, Claudia
Darnell, James E., Jr.
CELL, 2007, 131 (03)
[32] Cytokines and JAK-STAT signaling
Schindler, C
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) : 7 - 14
[33] JAK-STAT signaling in asthma
Pernis, AB
Rothman, PB
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (10): : 1279 - 1283
[34] Histological Outcomes and JAK-STAT Signalling in Ulcerative Colitis Patients Treated with Tofacitinib
van Gennep, Sara
Fung, Ivan C. N.
Jong, Djuna C. de
Ramkisoen, Rishand K.
Clasquin, Esme
de Jong, Jitteke
de Vries, Leonie C. S.
de Jonge, Wouter J.
Gecse, Krisztina B.
Lowenberg, Mark
Woolcott, John C.
Mookhoek, Aart
D'Haens, Geert R.
JOURNAL OF CROHNS & COLITIS, 2024, 18 (08): : 1283 - 1291
[35] TARGETING JAK-STAT SIGNALLING ALTERS THE PHENOTYPIC CHARACTERISTICS OF PsA SYNOVIAL FIBROBLASTS IN RESPONSE TO THE JAK/STAT ACTIVATOR ONCOSTATIN M
O' Brien, A.
Hanlon, M.
Marzaioli, V.
Flynn, K.
Wade, S.
Veale, D.
Fearon, U.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 435 - 435
[36] A systems biology approach to analyse amplification in the JAK2-STAT5 signalling pathway
Vera, Julio
Bachmann, Julie
Pfeifer, Andrea C.
Becker, Verena
Hormiga, Jose A.
Darias, Nestor V. Torres
Timmer, Jens
Klingmueller, Ursula
Wolkenhauer, Olaf
BMC SYSTEMS BIOLOGY, 2008, 2
[37] Continuous exposure to PEG-IFN-Alpha only transiently activates JAK-stat signalling in human liver
Makowska, Z.
Dill, M. T.
Vogt, J. E.
Filipowicz, M.
Terraciano, L.
Roth, V.
Heim, M. H.
CYTOKINE, 2012, 59 (03) : 563 - 564
[38] The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
O'Shea, John J.
Schwartz, Daniella M.
Villarino, Alejandro V.
Gadina, Massimo
McInnes, Iain B.
Laurence, Arian
ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 311 - 328
[39] Inhibition of interferon alpha signalling through the Jak-STAT pathway in HCV transgenic mice
Heim, MH
Blindenbacher, A
Stutvoet, S
Duong, F
Moradpour, D
Blum, HE
Tripodi, M
Lamonica, N
GASTROENTEROLOGY, 2001, 120 (05) : A7 - A8
[40] Inhibition of interferon alpha signalling through the Jak-STAT pathway in HCV transgenic mice
Heim, MH
Blindenbacher, A
Stutvoet, S
Duong, F
Moradpour, D
Blum, HE
Tripodi, M
La Monica, N
JOURNAL OF HEPATOLOGY, 2001, 34 : 25 - 26

← 1 2 3 4 5 →